Regeneron Launches $500M Venture Fund Led by Former Executives

- Regeneron, a biopharmaceutical company, has established a new venture arm with a $500 million commitment to invest in biotech and beyond.
- The venture fund is led by former Regeneron executives, indicating a focus on leveraging the expertise of experienced industry professionals.
- The fund aims to support innovative projects and companies in the biotech sector.
- The announcement was made on April 15, 2024.